XARELTO®: Extended treatment and reduction in the risk of recurrence in deep vein thrombosis (DVT) and pulmonary embolism (PE)
XARELTO® helps reduce the risk of recurrent DVT/PE—whether initiated inpatient or outpatient*1-7
◇For VTE prophylaxis in acutely ill medical patients at risk for thromboembolic complications who are not at high risk of bleeding.
*The decision regarding initiation setting should be based on the prescriber’s clinical judgment.
DVT = deep vein thrombosis; PE = pulmonary embolism; VTE = venous thromboembolism.